MCK - McKesson Corporation

Price: -- -- | CONSENSUS: Buy DETAILS | PRICE TARGET: $971.63 DETAILS

Stock News

Here's Why McKesson (MCK) is a Strong Growth Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Sep 02, 2026 06:45 AM • zacks.com

Hackers claim millions of patient records stolen during data breach at healthcare giant McKesson

A prolific hacking group has taken credit for last week's cyberattack against U.S. pharmaceutical distribution giant McKesson, leading to the latest spill of highly sensitive health data by an American healthcare company in recent months.

Aug 31, 2026 10:10 AM • techcrunch.com

Beacon Pointe Advisors LLC Purchases New Stake in McKesson Corporation $MCK

Beacon Pointe Advisors LLC purchased a new position in shares of McKesson Corporation (NYSE: MCK) in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 20,343 shares of the company's stock, valued at approximately $15,371,000. A number of other hedge funds and

Aug 28, 2026 11:57 PM • defenseworld.net

McKesson to Acquire Precision Medicine Group to Strengthen Services

MCK's $2.25B Precision Medicine Group deal aims to expand clinical research and commercialization services in oncology and multispecialty care.

Aug 27, 2026 08:26 AM • zacks.com

Here's Why You Should Retain McKesson Stock in Your Portfolio for Now

MCK's specialty distribution, oncology and technology businesses are fueling growth, while drug-pricing pressure and policy shifts pose risks.

Aug 25, 2026 09:06 AM • zacks.com

McKesson Buys Precision Medicine to Expand Clinical Research and Commercialization

McKesson Corporation (NYSE:MCK) on Tuesday announced an agreement to acquire Precision Medicine Group.

Aug 25, 2026 07:31 AM • benzinga.com

McKesson to buy Precision Medicine Group in about $2.25 billion deal

U.S. drug distributor McKesson said on Tuesday it would buy clinical research ⁠and biopharma commercialization services provider Precision Medicine Group in a deal valued at about $2.25 billion.

Aug 25, 2026 04:17 AM • reuters.com

McKesson Signs Agreement to Acquire Precision Medicine Group, LLC

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) announced today that it signed a definitive agreement to acquire Precision Medicine Group, LLC (“Precision Medicine Group”), a global provider of clinical research and biopharma commercialization services. McKesson will acquire Precision Medicine Group for approximately $2.25 billion. Following completion of the transaction, Precision Medicine Group will report within McKesson's Oncology & Multispecialty segment. The transacti.

Aug 25, 2026 04:00 AM • businesswire.com

McKesson Raises FY27 Guidance as Oncology and GLP-1 Growth Accelerate

McKesson raises fiscal 2027 EPS guidance as oncology, GLP-1 volumes and specialty distribution drive faster profit growth despite cash-flow pressure.

Aug 24, 2026 11:51 AM • zacks.com

Is McKesson Stock Worth Buying as Growth Meets a Premium Valuation?

McKesson's double-digit earnings growth, specialty expansion and capital returns support the story, but a premium valuation leaves less room for error.

Aug 24, 2026 11:51 AM • zacks.com

Algebris UK Ltd. Purchases Shares of 1,206 McKesson Corporation $MCK

Algebris UK Ltd. bought a new stake in McKesson Corporation (NYSE: MCK) during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 1,206 shares of the company's stock, valued at approximately $908,000. Other institutional investors and hedge funds have also added to

Aug 21, 2026 12:13 AM • defenseworld.net

2,797 Shares in McKesson Corporation $MCK Purchased by Aurora Investment Counsel

Aurora Investment Counsel purchased a new stake in shares of McKesson Corporation (NYSE: MCK) in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 2,797 shares of the company's stock, valued at approximately $2,113,000. A number of other institutional investors and hedge

Aug 19, 2026 11:48 PM • defenseworld.net

"Trumpflation" Is Real -- and Getting Worse. Here Are 2 Stocks That Turn Rising Prices Into Rising Profits.

These healthcare companies can actually benefit from inflation.

Aug 19, 2026 03:50 AM • fool.com

Alamar Capital Management LLC Takes $1.40 Million Position in McKesson Corporation $MCK

Alamar Capital Management LLC bought a new position in McKesson Corporation (NYSE: MCK) in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 1,844 shares of the company's stock, valued at approximately $1,395,000. A number of other large investors have also recently added

Aug 19, 2026 12:11 AM • defenseworld.net

Act Two Investors LLC Buys New Holdings in McKesson Corporation $MCK

Act Two Investors LLC bought a new position in McKesson Corporation (NYSE: MCK) during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 8,920 shares of the company's stock, valued at approximately $6,740,000. McKesson makes up about 1.4% of

Aug 19, 2026 12:11 AM • defenseworld.net

Focus Partners Advisor Solutions LLC Invests $1.29 Million in McKesson Corporation $MCK

Focus Partners Advisor Solutions LLC acquired a new stake in shares of McKesson Corporation (NYSE: MCK) in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 1,702 shares of the company's stock, valued at approximately $1,286,000. Several other hedge funds and other

Aug 17, 2026 01:40 AM • defenseworld.net

BIP Wealth LLC Invests $1.75 Million in McKesson Corporation $MCK

BIP Wealth LLC purchased a new stake in McKesson Corporation (NYSE: MCK) in the undefined quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 2,314 shares of the company's stock, valued at approximately $1,748,000. A number of other institutional investors have also recently modified their holdings of

Aug 14, 2026 11:30 PM • defenseworld.net

Here's Why McKesson (MCK) is a Strong Momentum Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Aug 10, 2026 06:50 AM • zacks.com

McKesson Q1 Earnings Call Highlights

McKesson NYSE: MCK reported fiscal first-quarter 2027 results that exceeded its expectations, citing broad-based momentum across its operating businesses and prompting the healthcare services company to raise its full-year adjusted earnings outlook.

Aug 08, 2026 10:05 AM • marketbeat.com

McKesson: Solid Q1 Earnings And Management Execution (Rating Upgrade)

McKesson delivered strong Q1 results, with EPS up 20% and revenues rising 7.7% while modestly raising FY27 EPS guidance. I see GLP-1-driven momentum decelerating alongside a broader dip in the company's top-line growth profile. The Wellverse spin-off and prior divestitures are streamlining MCK, potentially justifying a premium multiple versus peers.

Aug 08, 2026 04:00 AM • seekingalpha.com